PET-IMAGING OF HYPOXIA USING 89ZR-LABELED CG250-F(AB′)2

被引：0
|
作者：
Hoeben, B. [1 ]
Kaanders, J. [1 ]
Laverman, P. [2 ]
Oosterwijk, E. [3 ]
Oyen, W. [2 ]
Boerman, O. [2 ]
Bussink, J. [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Radiat Oncol, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Nucl Med, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Urol, Nijmegen, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 94卷
关键词：
D O I：
10.1016/S0167-8140(10)80004-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] PET of Hypoxia with 89Zr-Labeled cG250-F(ab′)2 in Head and Neck Tumors
    Hoeben, Bianca A. W.
    Kaanders, Johannes H. A. M.
    Franssen, Gerben M.
    Troost, Esther G. C.
    Rijken, Paul F. J. W.
    Oosterwijk, Egbert
    van Dongen, Guus A. M. S.
    Oyen, Wim J. G.
    Boerman, Otto C.
    Bussink, Johan
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) : 1076 - 1083
  • [2] PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats
    Brouwers, A
    Verel, I
    Van Eerd, J
    Visser, G
    Steffens, M
    Oosterwijk, E
    Corstens, F
    Oyen, W
    Van Dongen, G
    Boerman, O
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (02) : 155 - 163
  • [3] PET-imaging of 89Zr-labeled bispecific T-cell engagers in syngeneic tumor bearing mice
    Suurs, Frans V.
    de Groot, Derk J.
    Domanska, Urszula M.
    Lorenczewski, Grit
    Stienen, Sabine
    Friedrich, Matthias
    de Vries, Elisabeth G.
    Lub-de Hooge, Marjolijn N.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Molecular Design of 68Ga-and 89Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors
    Morath, Volker
    Brandt, Corinna
    Deuschle, Friedrich-Christian
    Mendler, Claudia T.
    Blechert, Birgit
    Summer, Dominik
    Barinka, Cyril
    Decristoforo, Clemens
    Weber, Wolfgang A.
    Schwaiger, Markus
    Skerra, Arne
    MOLECULAR PHARMACEUTICS, 2023, 20 (05) : 2490 - 2501
  • [5] PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes
    Bauer, David
    Visca, Hannah
    Weerakkody, Anuradha
    Carter, Lukas M.
    Samuels, Zachary
    Kaminsky, Spencer
    Andreev, Oleg A.
    Reshetnyak, Yana K.
    Lewis, Jason S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Noninvasive PET imaging of CD38 expression using 89Zr-labeled daratumumab in lymphoma
    Kang, Lei
    Jiang, Dawei
    Yu, Bo
    Ehlerding, Emily
    Ni, Dalong
    Barnhart, Todd
    Wang, Rongfu
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [7] An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients
    Dietlein, Felix
    Kobe, Carsten
    Vazquez, Sergio Munoz
    Fischer, Thomas
    Endepols, Heike
    Hohberg, Melanie
    Reifegerst, Manuel
    Neumaier, Bernd
    Schomaecker, Klaus
    Drzezga, Alexander E.
    Dietlein, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (04) : 573 - 583
  • [8] Biodistribution studies of 89Zr-labeled nanodiamonds in mice using PET and MRI
    Eberhardt, Nina
    Loeffler, Jessica
    Raabe, Marco
    Li, Hao
    Abaei, Alireza
    Herrmann, Hendrik
    Solbach, Christoph
    Weil, Tanja
    Beer, Ambros
    Rasche, Volker
    Winter, Gordon
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [9] PET imaging of 89Zr-labeled Pertuzumab in HER2-positive breast cancer xenografts
    Marquez, Bernadette V.
    Ikotun, Oluwatayo F.
    Wright, Brian
    Zheleznyak, Alexander
    Richard, Pierce
    Lapi, Suzanne E.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Preliminary evaluation of 89Zr-Labeled Affibody for PET imaging of Tumors Expressing HER2
    Xu, Y.
    Bai, Z.
    Pan, D.
    Wang, L.
    Yan, J.
    Yang, R.
    Yang, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S656 - S656
12345